United Therapeutics Corp. (UTHR)
584.21
-3.67
(-0.62%)
USD |
NASDAQ |
Nov 17, 16:00
584.21
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Price : 584.21 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 592.27 | 595.66 | 578.71 | 587.88 | 441674.0 |
| Nov 13, 2026 | 593.31 | 598.84 | 587.00 | 591.17 | 463509.0 |
| Nov 12, 2026 | 597.50 | 598.38 | 586.56 | 593.31 | 338727.0 |
| Nov 11, 2026 | 588.36 | 598.80 | 583.80 | 595.66 | 369687.0 |
| Nov 10, 2026 | 580.07 | 593.10 | 577.26 | 588.61 | 461369.0 |
| Nov 09, 2026 | 570.47 | 586.46 | 556.63 | 582.46 | 571822.0 |
| Nov 06, 2026 | 561.95 | 569.45 | 559.41 | 562.02 | 468563.0 |
| Nov 05, 2026 | 608.29 | 608.29 | 561.24 | 565.72 | 619733.0 |
| Nov 04, 2026 | 583.63 | 614.23 | 578.28 | 608.49 | 946056.0 |
| Nov 03, 2026 | 596.14 | 606.72 | 596.14 | 601.32 | 611879.0 |
| Nov 02, 2026 | 596.54 | 600.90 | 592.46 | 596.13 | 419870.0 |
| Oct 30, 2026 | 600.00 | 609.99 | 593.57 | 598.72 | 518241.0 |
| Oct 29, 2026 | 591.76 | 599.45 | 589.62 | 593.54 | 370341.0 |
| Oct 28, 2026 | 581.94 | 589.19 | 581.88 | 586.48 | 421675.0 |
| Oct 27, 2026 | 587.10 | 593.00 | 582.66 | 591.20 | 457447.0 |
| Oct 26, 2026 | 589.11 | 593.50 | 584.50 | 592.84 | 577007.0 |
| Oct 23, 2026 | 584.92 | 590.98 | 576.24 | 587.50 | 637876.0 |
| Oct 22, 2026 | 568.69 | 590.79 | 562.86 | 584.79 | 895459.0 |
| Oct 21, 2026 | 553.63 | 566.55 | 550.06 | 563.49 | 455094.0 |
| Oct 20, 2026 | 547.14 | 564.97 | 545.58 | 553.88 | 443279.0 |
| Oct 19, 2026 | 539.10 | 560.00 | 534.61 | 543.15 | 498298.0 |
| Oct 16, 2026 | 545.49 | 551.76 | 530.18 | 533.12 | 668250.0 |
| Oct 15, 2026 | 545.24 | 551.82 | 538.07 | 541.51 | 545401.0 |
| Oct 14, 2026 | 543.18 | 546.89 | 523.95 | 540.03 | 883183.0 |
| Oct 13, 2026 | 551.59 | 553.99 | 542.23 | 543.40 | 538231.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Liquidia Corp. | 56.79 |
| Alnylam Pharmaceuticals, Inc. | 156.54 |
| Exelixis, Inc. | 68.50 |
| Gilead Sciences, Inc. | 170.43 |
| Insmed, Inc. | 121.90 |
Price Related Metrics
| PE Ratio | 22.04 |
| PS Ratio | 8.504 |
| PEG Ratio | 48.34 |
| Price to Book Value | 3.945 |
| Price to Free Cash Flow | 31.38 |
| Earnings Yield | 4.54% |
| Market Cap | 24.76B |
| PEGY Ratio | 48.34 |
| Operating PE Ratio | 19.52 |
| Normalized PE Ratio | 22.96 |